Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Addiction. 2010 Nov 4;106(2):357–365. doi: 10.1111/j.1360-0443.2010.03149.x

Table 1.

Sample characteristics in the Center for Interdisciplinary Research on AIDS (CIRA) syringe exchange program (SEP) survey (with data from the 2007 Beth Israel national SEP survey provided for sample comparison) (n = 111).

CIRA survey,
n (%)
Beth Israel survey,
n (%)[44]
SEPs participating 111 (60) 131 (70)
Volume of exchange (units/year)
 Small (<10 000) 10 (11) 23 (18)
 Medium (10 000–55 000) 29 (31) 37 (28)
 Large (55 001–499 999) 42 (45) 57 (44)
 Very large (>500 000) 13 (14) 13 (10)
SEP services offered
 Naloxone distribution 45 (41) 52 (40)
 Condom distribution 111 (100) 130 (99)
 Drug treatment referrals 105 (96) 120 (92)
 HIV testing 31 (28) 115 (88)1
 HBV testing 24 (22) 30 (23)2
Region
 Northeast 30 (29) 31 (23)
 South 11 (11) 13 (10)
 West 42 (40) 61 (47)
 Midwest 22 (20) 26 (20)
Modal race/ethnicity of clientele3
 White 69 (72)
 African American 18 (19)
 Hispanic 8 (18)
Distribution modalities
 Stationary 81 (73)
 Mobile 62 (57)
 Delivery 39 (36) 59 (45)
 All three 23 (21)
Program setting
 Urban only 44 (40)
 Suburban only 20 (18)
 Rural only 8 (7)
 Urban and suburban 10 (9)
 Urban and rural 11 (10)
 Suburban and rural 9 (8)
 All three 2 (2)
Legal environment
 SEP operating illegally 29 (26)
 Any syringe possession w/o prescription legal 50 (47)
 Syringe possession w/o prescription legal only for SEP clients 72 (65)
Operated by department of health 21 (26) 34 (26)4
Receiving state funding 61 (63) 67 (52)
1

Includes any HIV counseling or testing.

2

Includes any hepatitis B virus (HBV) counseling or testing.

3

No respondent indicated Asian, Native American, Pacific Islander or Other as the modal category.

4

Operated by city, county or state government.